Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial
- Lancet Rheumatol., May 03 2024, S2665-9913(24)00084-5 | https://doi.org/10.1016/S2665-9913(24)00084-5